Mint Tower Capital Management’s Verona Pharma VRNA Stock Holding History

Mint Tower Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,134	Closed	-$334K	–	286
2025 Q3	$334K	Buy	+3,134	New	+$327K	0.04%	129

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Mint Tower Capital Management's VRNA Position: Q4 2025 in Review

Mint Tower Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 3,134 shares — an estimated $334K sold.

Mint Tower Capital Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $334K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Mint Tower Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Mint Tower Capital Management sold 3,134 Verona Pharma shares in Q4 2025, an estimated $334K.
Mint Tower Capital Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Mint Tower Capital Management's Verona Pharma position peaked at $334K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Mint Tower Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.